Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2005
11/02/2005EP0970119B1 Synaptic activation protein compositions and method
11/02/2005EP0956357B1 Invertase inhibitor
11/02/2005EP0951537B1 Recombinant collagen produced by plants, methods for obtaining them and uses
11/02/2005EP0906435B1 Enhancement of gene expression
11/02/2005EP0901521B1 Antigenic modulation of cells
11/02/2005EP0778842B1 Mammalian telomerase
11/02/2005CN1692156A Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692124A P53 binding T cell receptor molecules and uses thereof
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1690193A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/02/2005CN1225559C Rice flavamonocell hrf3 gene, recombinant vector and breeding method for plant transgene
11/02/2005CN1225556C Recombinant nucleic acid of coded human osteogenic protein-1 and its application
11/02/2005CN1225555C Human TOLL-like receptor proteins, related reagents and methods
11/01/2005US6960709 Method for altering the nutritional content of plant seed
11/01/2005US6960708 Seed and plant; regeneration from tissue culture of protoplasts; cross-pollenation as male or female parent
11/01/2005US6960706 Genetic engineering; fungi tolerance; chemical resistance
11/01/2005US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors
11/01/2005US6960473 In vitro mass production of human erythroid cells from the blood of normal donors and thalassemic patients
11/01/2005US6960471 For cancer diagnostics
11/01/2005US6960470 Diagnostic methods for drug screening for Alzheimer's disease
11/01/2005US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
11/01/2005US6960459 Cutinase variants
11/01/2005US6960446 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005US6960440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/01/2005US6960435 Amyloid β protein agglutination-controlling factor
11/01/2005US6960434 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells
11/01/2005US6960428 Storage and maintenance of platelets
11/01/2005US6960427 Generating three-dimensional biocompatible artificial tissue; obtain tissue, insert into bioreactor, mix with growth factors, propagate tissue, recover tissue
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005CA2349823C System and sequential culture media for in vitro fertilization
11/01/2005CA2303526C Hepatitis c virus cell culture system
11/01/2005CA2294078C C-peptide specific assay procedure
11/01/2005CA2274877C In culture proliferation of human pancreatic endocrine cells
11/01/2005CA2157063C Recombinant dna viral vector for transfecting animal cells
11/01/2005CA2075515C Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor
10/2005
10/27/2005WO2005101014A2 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100565A1 Novel fluorescent protein and gene coding for the same
10/27/2005WO2005100564A2 Intervention in the energy metabolism of eukaryote cells for the purposes of selection and increased expression
10/27/2005WO2005100563A1 Follistatin mutant polypeptide
10/27/2005WO2005100561A1 Translation controlling polynucleotide
10/27/2005WO2005100559A1 Extranuclear rna splicing in neuronal dendrites
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100553A2 Method for assessment of cytotoxic lymphocyte activity
10/27/2005WO2005100552A2 Cells exhibiting neuronal progenitor cell characteristics
10/27/2005WO2005100551A1 In vitro method for isolating, proliferating and differentiating germ-line stem cells
10/27/2005WO2005100550A1 Method of cell transdifferentiation
10/27/2005WO2005100549A1 Method of proliferating organ-specific stem cell and proliferation apparatus therefor
10/27/2005WO2005100548A1 Process for producing multipotential stem cell originating in testoid cell
10/27/2005WO2005100547A1 Dendritic cell obtained by antigen pulsing
10/27/2005WO2005100546A1 Reversibly immortalized mammalian liver cells and use thereof
10/27/2005WO2005100545A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
10/27/2005WO2005100403A2 Antibodies to erythropoietin receptor and uses thereof
10/27/2005WO2005100401A2 Monoclonal antibodies with specificity for fetal erythroid cells
10/27/2005WO2005100390A2 Bob-1 specific t cells and methods to use
10/27/2005WO2005099758A2 Injectable bioartificial tissue matrix
10/27/2005WO2005099741A1 Remedy for motoneuron diseases
10/27/2005WO2005099449A2 Animal model, cells, and treatment for malignant melanoma
10/27/2005WO2005063966A3 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells
10/27/2005WO2005063813A3 Process for the production of tumor necrosis factor-binding proteins
10/27/2005WO2005037985A3 Composition and methods for cell culturing and tissue culture platforms
10/27/2005WO2005010139B1 Ferromagnetic cell and tissue culture microcarriers
10/27/2005WO2005007825A3 Modulation of aminopeptidase n expression
10/27/2005WO2005000870A3 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2004078917A3 Expansion of renewable stem cell populations using modulators of pi 3-kinase
10/27/2005WO2003102016A3 Amyloid peptide inactivating enzyme to treat alzheimer's disease
10/27/2005WO2003054163A3 Methods for producing hyaluronan in a recombinant host cell
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050241021 Acetolactate synthase gene promoter
10/27/2005US20050241016 Plant centromere compositions
10/27/2005US20050241015 Glycine max plant cell with minichromosome that is not integrated into genome and comprises centromere sequence which confers ability to segregate to daughter cells and at least 5 repeated nucleotide sequences; genetic engineering
10/27/2005US20050241013 Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization
10/27/2005US20050241007 Frog prince, a transposon vector for gene transfer in vertebrates
10/27/2005US20050240281 Fiber-reinforced, porous, biodegradable implant device
10/27/2005US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease
10/27/2005US20050239897 Mesenchymal stem cells and uses therefor
10/27/2005US20050239735 Enhancement of immune responses
10/27/2005US20050239729 Incorporating the pro-apoptotic protein BAX and autoantigens adenoviral protein E3-GP19k and Delta BCL-2 into an injectable antidiabetic or hypoglycemic formulation; prevention, diagnosis and monitoring of diabetic patients
10/27/2005US20050239708 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
10/27/2005US20050239696 Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
10/27/2005US20050239205 Gb virus b based replicons and replicon enhanced cells
10/27/2005US20050239203 Regulation of endogenous gene expression in cells using zinc finger proteins
10/27/2005US20050239201 Methods of inducing differentiation of stem cells into a specific cell lineage
10/27/2005US20050239187 Methods to culture circovirus
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239051 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/27/2005US20050239043 Subtilisin carlsberg proteins with reduced immunogenicity
10/27/2005US20050239042 Novel cellular compositions and methods for their preparation
1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 1827